Successful treatment of sternal fracture nonunion with teriparatide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Fractures have a significant impact on the quality of life for the patient in addition to an enormous indirect cost in lost productivity for our economy. While majority of fractures heal uneventfully, some fail to heal even after many months resulting in nonunion.
Sternal nonunions, although rare, are particularly onerous for the patient given the magnitude of impact on quality of life.
Current treatment for fracture nonunions emphasizes various approaches to surgical fixation in addition to bone grafting. These treatments are aggressive and have a variety of drawbacks, rendering them suboptimal as a therapeutic approach.
Based on the success of teriparatide in animal studies to accelerate fracture healing, there is growing interest in using this drug in humans for the same purpose. We report a case of what we believe to be the first successful use of teriparatide in the healing of a sternal nonunion fracture.
- Bishop GB, Einhorn TA (2007) Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 31:721–727 CrossRef
- Axelrad TW, Kakar S, Einhorn TA (2007) New technologies for the enhancement of skeletal repair. Injury 38S1:S49–S62
- Busse JW, Bhandari M, Sprague S, Johnson-Masotti AP, Gafni A (2005) An economic analysis of management strategies for closed and open grade 1 tibial shaft fractures. Acta Orthop 76:705–712 CrossRef
- Wu LC, Renucci JD, Song DH (2005) Sternal nonunion: a review of current treatments and a new method of rigid fixation. Ann Plast Surg 54:55–58 CrossRef
- Johnson I, Branfoot T (1992) Sternal fracture-a modern review. Arch Emerg Med 10:24–28 CrossRef
- Richardson JD, Franklin GA, Heffley S, Seligson D (2007) Operative fixation of chest wall fractures: an underused procedure? Am Surg 73:591–596
- Barnes GL, Kakar S, Vora S, Morgan EF, Gerstenfeld LC, Einhorn TA (2008) Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. J Bone Joint Surg Am 90(Suppl1):120–127 CrossRef
- Brinker MR, O’Connor DP, Monla YT, Earthman TP (2007) Metabolic and endocrine abnormalities in patients with nonunions. J Orthop Trauma 21:557–570 CrossRef
- Mahendra A, Maclean AD (2007) Available biological treatments for complex non-unions. Injury 38S4:S7–S12 CrossRef
- Finkemeier CG (2002) Bone-grafting and bone-graft substitute. J Bone Joint Surg Am 84-A:454–464
- U.S. Food and Drug Administration. INFUSE® Bone Graft Important Medical Information. Available via http://www.fda.gov/cdrh/PDF4/p000054c.pdf.Accessed 29 March 2009.
- U.S. Food and Drug Administration Center For Devices And Radiological Health. New Humanitarian Device Approval OP-1 Putty – H020008. Available via http://www.fda.gov/cdrh/MDA/DOCS/h020008.html. Accessed 29 March 2009.
- Skripitz R, Aspenberg P (2004) Parathyroid hormone-a drug for orthopedic surgery? Acta Orthop Scand 75:654–662 CrossRef
- Selye H (1932) On the stimulation of new bone formation with parathyroid extract and irradiated ergosterol. Endocrinology 16:547–558 CrossRef
- Dobnig H, Turner RT (1997) The effects of programmed administration of human parathyroid hormone fragment (1–34) on bone histomorphometry and serum chemistry in rats. Endocrinology 138:4607–4612 CrossRef
- Knecht TP (2004) Teriparatide and fracture healing in cortical bone. Endocr Pract 10:293
- Resmini G, Iolascon G (2007) 79-year-old post-menopausal woman with humerus fracture during teriparatide treatment. Aging Clin Exp Res 19(4Suppl):30–31
- Tarantino U, Cannata G, Cerocchi I, Lecce D, Iundusi R, Celi M (2007) Surgical approach to fragility fractures: problems and perspectives. Aging Clin Exp Res 19(4Suppl):12–21
- Successful treatment of sternal fracture nonunion with teriparatide
Volume 21, Issue 6 , pp 1059-1063
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Fracture healing
- Industry Sectors